Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil
Open Access
- 10 May 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 49 (8), 1590-1593
- https://doi.org/10.1093/rheumatology/keq134
Abstract
Objectives. To evaluate the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies and RF in RA patients and their relatives from Southern Brazil. Methods. Anti-CCP2 and IgM-RF were evaluated in 156 RA patients and 200 relatives. Sera from 100 healthy unrelated individuals were used as control. The anti-CCP2 was detected by ELISA and the IgM-RF using the latex agglutination test. Results. We identified 117 anti-CCP2 (75%)-positive and 106 RF (67.9%)-positive patients. Anti-CCP2 was increased in relatives (5.5%; 11/200) when compared with unrelated individuals (1%; P = 0.050). Titre of anti-CCP2 in RA patients did not differ from relatives [140.4 (75.7) vs 115.6 (84.2) U, respectively; P = 0.30]. Positive relatives were younger than patients for anti-CCP2 (P = 0.0081), RF (P < 0.001) and both concomitantly (P = 0.012), and although there was no difference for anti-CCP2 positivity according to gender, increased RF positivity and concomitant anti-CCP2/RF were observed in the female relatives (P = 0.067 and 0.082, respectively). No difference regarding the relative degree of tobacco use in relatives was detected. Among the 11 anti-CCP2-positive relatives, 2 females had RA diagnosis established and 6 individuals presented with joint symptoms suggestive of RA. Conclusion. The results demonstrate a significant positivity of anti-CCP2 in relatives of RA patients from Brazil and reinforce the importance of serological tools to identify undiagnosed RA.This publication has 17 references indexed in Scilit:
- Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritisJournal of Autoimmunity, 2009
- Familial associations of rheumatoid arthritis with autoimmune diseases and related conditionsArthritis & Rheumatism, 2009
- Anti‐CCP Antibody, a Marker for the Early Detection of Rheumatoid ArthritisAnnals of the New York Academy of Sciences, 2008
- Marked differences in fine specificity and isotype usage of the anti–citrullinated protein antibody in health and diseaseArthritis & Rheumatism, 2008
- Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid ArthritisAnnals of Internal Medicine, 2007
- Triagem sorológica de familiares de pacientes com doença celíaca: anticorpos anti-endomísio, antitransglutaminase ou ambos?Arquivos de Gastroenterologia, 2007
- Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2004
- Development of Autoantibodies before the Clinical Onset of Systemic Lupus ErythematosusThe New England Journal of Medicine, 2003
- The benefits of early treatment in rheumatoid arthritis: Confounding by indication, and the issue of timingArthritis & Rheumatism, 2003
- Rheumatoid arthritisThe Lancet, 2001